GSMA
6.6.2018 10:02:09 CEST | Business Wire | Press release
As part of its role within the W20 (Women 20) group1 , the GSMA has backed a series of recommendations to promote digital inclusion for women to be presented to the G20 member states later this year. The GSMA is Topic Chair of the Digital Inclusion theme within the W20, which is advising the G20 on issues around gender equality and the economic empowerment of women, supporting the Sustainable Development Goals (SDGs), particularly SDG #5 (Gender Equality).
“The GSMA has been privileged to help shape the W20 recommendations, which will provide an actionable roadmap for the G20 nations to drive gender equality policies around the world,” said Mats Granryd, Director General of the GSMA. “These recommendations underline the importance of closing the digital gender gap by removing barriers to access and use, and promoting policies that encourage the digital inclusion of women. We believe this approach will ensure women and girls play a major role in shaping our future digital economies.”
“Ensuring that women are digitally included brings significant benefits for them and for their communities and economies”, added Susana Balbo, Chair of the W20.
At a W20 roundtable in Paris last week, the GSMA chaired the debate between the W20 delegates to set the Digital Inclusion recommendations. There are four agreed recommendations that call on G20 member states to:
1) Collect, track and analyse data on women’s access to and use of digital technologies and on the presence of women in STEM-related courses, careers and in leadership positions;
2) Develop holistic policies that focus on the barriers to women’s access to and use of digital technologies including accessibility, affordability, safety and security, digital skills and availability of relevant content and services;
3) Promote initiatives that drive equal participation of women and girls in STEM studies and digital-intensive work to ensure that women participate and lead in the design, development and governance of digital technologies, as well as entrepreneurs in the digital sector;
4) Ensure that all analyses of the future of work, including education needs and demands for new skills, are performed with a view to gender balance, social protection and job quality.
These recommendations feed into what will be presented at the G20 Argentina 2018 summit taking place in Buenos Aires, 30 November – 1 December 2018, where the G20 governments will be asked to make concrete commitments on each issue.
Mobile Industry Supporting Digital Inclusion for Women
The
GSMA is committed to supporting increased digital and financial
inclusion for women, reflecting the fact that mobile is the primary way
for people to access the internet in many parts of the world. However,
according to the latest GSMA research2
, women in low- and
middle-income countries are 26 percent less likely than men to use
mobile internet.
As part of the GSMA’s Connected Women initiative, 36 mobile operators across Africa, Asia and Latin America have made 51 formal commitments to reduce the gender gap in their mobile money or mobile internet customer base, driving an effort to accelerate digital and financial inclusion for women. To date, the Connected Women programme and its mobile operator partners have delivered life-enhancing services to more than 22 million women.
As well as the Connected Women programme and its participation in W20 , the GSMA also supports efforts to accelerate digital and financial inclusion for women via its participation in W20 ; the EQUALS initiative; the GSMA Connected Women programme; Women4Tech ; the WeCare initiative in Latin America; and the #BetterFuture campaign.
-ENDS-
About the GSMA
The GSMA represents the interests of mobile
operators worldwide, uniting nearly 800 operators with more than 300
companies in the broader mobile ecosystem, including handset and device
makers, software companies, equipment providers and internet companies,
as well as organisations in adjacent industry sectors. The GSMA also
produces industry-leading events such as Mobile World Congress, Mobile
World Congress Shanghai, Mobile World Congress Americas and the Mobile
360 Series of conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA .
________________________
1
The W20 is one of seven
independent engagement groups comprised of civil society organisations
from the G20 member counties. The engagement groups convene in tandem
with the G20 and ensure that the position of civil society on important
issues is taken on board by the G20 leaders. For more information see http://w20argentina.com
2
https://www.gsma.com/mobilefordevelopment/programmes/connected-women/the-mobile-gender-gap-report-2018
View source version on businesswire.com: https://www.businesswire.com/news/home/20180606005078/en/
Contact:
For the GSMA
Beau Bass
+44 79 7662 4962
beau.bass@webershandwick.com
or
GSMA
Press Office
pressoffice@gsma.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
